---
figid: PMC7503842__ijms-21-06247-g002
figtitle: Aberrant Wnt signaling favors disease progression in leukemia
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
- Lareunionomyces loeiensis
pmcid: PMC7503842
filename: ijms-21-06247-g002.jpg
figlink: pmc/articles/PMC7503842/figure/ijms-21-06247-f002/
number: F2
caption: Aberrant Wnt signaling favors disease progression in leukemia. Mesenchymal
  stem/stromal cells (MSCs) not only directly produce Wnt, C1q, N-cadherin, and galectin-3
  while decrease BMP4 initiating Wnt signaling in leukemia stem cells (LSCs), but
  also differentiate into endothelial cells and osteoblasts, which support LSCs as
  well. Activated Wnt signaling mediates LSC self-renewal and drug resistance, thereby
  promoting leukemogenesis. Endothelial cells are not only able to transdifferentiate
  to MSCs called endothelial–mesenchymal transition (EndMT) effect, but also form
  new blood vessels called angiogenesis by which LSCs metastasize. Wnt signaling facilitates
  osteoblast differentiation into osteocytes; meanwhile, osteoblasts promote drug
  resistance of LSC through osteopontin (Opn) and the integrin pathway. AML, acute
  myeloid leukemia; CML, chronic myeloid leukemia; ALL, acute lymphoblastic leukemia;
  CLL, chronic lymphoblastic leukemia.
papertitle: Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.
reftext: Yongsheng Ruan, et al. Int J Mol Sci. 2020 Sep;21(17):6247.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9425645
figid_alias: PMC7503842__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC7503842__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7503842__ijms-21-06247-g002.html
  '@type': Dataset
  description: Aberrant Wnt signaling favors disease progression in leukemia. Mesenchymal
    stem/stromal cells (MSCs) not only directly produce Wnt, C1q, N-cadherin, and
    galectin-3 while decrease BMP4 initiating Wnt signaling in leukemia stem cells
    (LSCs), but also differentiate into endothelial cells and osteoblasts, which support
    LSCs as well. Activated Wnt signaling mediates LSC self-renewal and drug resistance,
    thereby promoting leukemogenesis. Endothelial cells are not only able to transdifferentiate
    to MSCs called endothelial–mesenchymal transition (EndMT) effect, but also form
    new blood vessels called angiogenesis by which LSCs metastasize. Wnt signaling
    facilitates osteoblast differentiation into osteocytes; meanwhile, osteoblasts
    promote drug resistance of LSC through osteopontin (Opn) and the integrin pathway.
    AML, acute myeloid leukemia; CML, chronic myeloid leukemia; ALL, acute lymphoblastic
    leukemia; CLL, chronic lymphoblastic leukemia.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Msc
  - Cdh2
  - Bmp4
  - Amhr2
  - Spp1
  - Mtor
  - Pik3r1
  - Vegfa
  - Foxm1
  - Cd82
  - Six1
  - Cd27
  - Ptp4a3
  - Myc
  - Nol3
  - Cd70
  - Arhgef1
  - Akt1
  - pk
  - Axin2
  - COX2
  - Ptgs2
  - MSC
  - SLC25A37
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CDH2
  - BMP4
  - SPP1
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - FOXM1
  - CD82
  - HNF4A
  - SIX1
  - CD27
  - PTP4A3
  - MYC
  - CD70
  - ARHGEF1
  - AKT1
  - AKT2
  - AKT3
  - BCR
  - AXIN2
  - PTGS2
  - MTCO2P12
  - msc
  - cdh2
  - bmp4
  - mtor
  - vegfaa
  - foxm1
  - cd82b
  - elk4
  - six1b
  - cd27
  - myca
  - mycbp2
  - axin2
  - AML
  - ALL
  - Leukemia
---
